# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 2725 results.
NeoVax With Nivolumab in Patients With Ovarian Cancer
Status: Not yet recruiting
Last Changed: Sep 28, 2020
First Received: Jul 18, 2019
Disease(s): Ovarian Cancer
Intervention(s): Nivolumab, NeoVax, Core Needle Biopsy
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Status: Recruiting
Last Changed: Jul 08, 2020
First Received: Apr 09, 2020
Disease(s): Ovarian Cancer
Intervention(s): Zafirlukast
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer
Status: Recruiting
Last Changed: Apr 23, 2019
First Received: Apr 23, 2019
Disease(s): Ovarian Cancer
Intervention(s): Anlotinib
Locations: The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Status: Recruiting
Last Changed: Jan 27, 2020
First Received: May 22, 2018
Disease(s): Ovarian Cancer
Intervention(s): Enoxaparin, Enoxaparin + Rosuvastatin, Thromboprophylaxis
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA
Status: Completed
Last Changed: Jun 10, 2019
First Received: Jul 25, 2017
Disease(s): Ovarian Cancer
Locations: Research Site, Aichi, Japan
Research Site, Akita, Japan
Research Site, Aomori, Japan
Research Site, Chiba, Japan
Research Site, Fukuoka, Japan
... and 31 other locations.
Platino-resistance in Ovarian Cancer
Status: Recruiting
Last Changed: May 08, 2020
First Received: May 17, 2019
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Patients treated with platinum based-chemotherapy
Locations: Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jan 03, 2020
First Received: Jan 03, 2020
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology
Status: Unknown status
Last Changed: Jan 16, 2018
First Received: Jul 17, 2017
Disease(s): Ovarian Cancer
Intervention(s): Caiman® device
Locations: Catholic University of Sacred Heart Rome,, Rome,, Rome, Italy
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Status: Completed
Last Changed: Jan 18, 2020
First Received: May 25, 2017
Disease(s): Ovarian Cancer
Intervention(s): Chiauranib
Locations: Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
Status: Active, not recruiting
Last Changed: Jul 22, 2020
First Received: Sep 25, 2014
Disease(s): Ovarian Cancer
Intervention(s): Cytoreductive Surgery (CRS), Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Neoadjuvant Chemotherapy (NACT), Adjuvant Chemotherapy, Fast-track recovery strategy